Literature DB >> 10082123

Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus.

S V Joag1, Z Li, C Wang, L Foresman, F Jia, E B Stephens, W Zhuge, O Narayan.   

Abstract

Macaques inoculated orally, vaginally, or parenterally with SHIV(KU-1) develop severe systemic infection, acute loss of CD4+ T cells, and AIDS. We showed in a previous report that passive immunization with neutralizing serum protected macaques against infection with parenterally inoculated pathogenic SHIV given 24 hr later. In the study reported here we asked whether the identical passive immunization protocol would protect macaques against infection with pathogenic SHIV following oral inoculation of the virus. Ten pigtail macaques were inoculated orally with one animal infectious dose of SHIV(KU-1). Four of the 10 had been given pooled anti-SHIV plasma (15 ml/kg) 24 hr earlier, 4 others were given the same dose of anti-SHIV plasma 2 hr after virus challenge, and the 2 remaining animals were used as controls. The neutralizing antibodies failed to protect macaques against infection after mucosal challenge with SHIV(KU-1).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082123     DOI: 10.1089/088922299311367

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

Review 1.  Immunotherapies to prevent mother-to-child transmission of HIV.

Authors:  Mark D Hicar
Journal:  Curr HIV Res       Date:  2013-03       Impact factor: 1.581

2.  Challenges of antibody-mediated protection against HIV-1.

Authors:  George K Lewis
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

Review 3.  Survivors Remorse: antibody-mediated protection against HIV-1.

Authors:  George K Lewis; Marzena Pazgier; Anthony L DeVico
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

4.  A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.

Authors:  Dinesh K Singh; Zhenqian Liu; Darlene Sheffer; Glenn A Mackay; Marilyn Smith; Sukhbir Dhillon; Ramakrishna Hegde; Fenglan Jia; Istvan Adany; Opendra Narayan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.

Authors:  Indresh K Srivastava; Leonidas Stamatatos; Harold Legg; Elaine Kan; Anne Fong; Stephen R Coates; Louisa Leung; Mark Wininger; John J Donnelly; Jeffrey B Ulmer; Susan W Barnett
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.

Authors:  Kristina Abel; Tracy Rourke; Ding Lu; Kristen Bost; Michael B McChesney; Christopher J Miller
Journal:  J Infect Dis       Date:  2004-09-24       Impact factor: 5.226

7.  Polymorphisms and interspecies differences of the activating and inhibitory FcγRII of Macaca nemestrina influence the binding of human IgG subclasses.

Authors:  Halina M Trist; Peck Szee Tan; Bruce D Wines; Paul A Ramsland; Eva Orlowski; Janine Stubbs; Elizabeth E Gardiner; Geoffrey A Pietersz; Stephen J Kent; Ivan Stratov; Dennis R Burton; P Mark Hogarth
Journal:  J Immunol       Date:  2013-12-16       Impact factor: 5.422

8.  Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS.

Authors:  S V Joag; Z Q Liu; E B Stephens; M S Smith; A Kumar; Z Li; C Wang; D Sheffer; F Jia; L Foresman; I Adany; J Lifson; H M McClure; O Narayan
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.